Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive hypophosphatemic rickets (ARHR) is a hereditary renal phosphate-wasting disorder characterized by hypophosphatemia, rickets and/or osteomalacia and slow growth.
Estimated prevalence: Unknown (Unknown prevalence).
4 clinical trials registered. Interventions under study include drug therapy. Pipeline includes 2 PHASE3, 1 PHASE2, 1 PHASE1. Research is primarily industry-sponsored.
28 publications have been identified in PubMed for autosomal recessive hypophosphatemic rickets. Research spans Review / Meta-Analysis (29%), Case Report / Case Series (29%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 8 | 29% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:07 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies |
8 |
29% |
Disease patterns and progression | 5 | 18% |
Laboratory research | 4 | 14% |
Other research | 2 | 7% |
Clinical study results | 1 | 4% |
Sawalha NA (2026). [PMID: 41820620](https://pubmed.ncbi.nlm.nih.gov/41820620/). *Calcif Tissue Int*. [Clinical Trial Publication]
Munteanu M (2026). [PMID: 41176198](https://pubmed.ncbi.nlm.nih.gov/41176198/). *Bone*. [Case Report / Case Series]
Al Qanoobi M (2026). [PMID: 41665285](https://pubmed.ncbi.nlm.nih.gov/41665285/). *J Bone Miner Res*. [Review / Meta-Analysis]
Bruno I (2026). [PMID: 41770448](https://pubmed.ncbi.nlm.nih.gov/41770448/). *J Endocrinol Invest*. [Review / Meta-Analysis]
Bruneau H (2026). [PMID: 42138629](https://pubmed.ncbi.nlm.nih.gov/42138629/). *Arch Endocrinol Metab*. [Review / Meta-Analysis]
Ferreira CR (2025). [PMID: 40176950](https://pubmed.ncbi.nlm.nih.gov/40176950/). *JBMR Plus*. [Epidemiology / Natural History]
Mehak NU (2025). [PMID: 40219799](https://pubmed.ncbi.nlm.nih.gov/40219799/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Srivastava S (2025). [PMID: 41251406](https://pubmed.ncbi.nlm.nih.gov/41251406/). *J Bone Miner Res*. [Basic Science / Preclinical]
Parmar A (2025). [PMID: 39778955](https://pubmed.ncbi.nlm.nih.gov/39778955/). *BMJ Case Rep*. [Case Report / Case Series]
Bertamino M (2025). [PMID: 41257790](https://pubmed.ncbi.nlm.nih.gov/41257790/). *Orphanet J Rare Dis*. [Basic Science / Preclinical]